macular degeneration
Genosity Inks Deal With Gemini Therapeutics to Develop Assay for AMD Clinical Trial Patient Selection
The assay will be used to select patients for enrollment in a Phase IIa study of Gemini Therapeutics' dry age-related macular degeneration drug GEM103.
Researchers from startup Duality Technologies and Dana-Farber have demonstrated the efficacy and speed of a highly secure technique for analyzing encrypted genomic data.
Age-Related Macular Degeneration Genes Revealed in Transcriptome Studies
A team led by National Eye Institute researchers picked out B3GLCT and BLOC1S1 as the most plausible target genes in an age-related macular degeneration analysis.
Inherited Retinal Disease Patients, Therapy Developers May Benefit From New Genetic Testing Program
Premium
To study the benefit of genetic testing data, the Foundation Fighting Blindness offered free clinical testing to 100 members of its My Retina Tracker patient registry.
International Consortium IDs New Loci Linked to Age-Related Macular Degeneration
The International AMD Genomics Consortium has uncovered 34 AMD-associated loci, including a site with specific ties to the wet AMD subtype.